<>

Our Board:

 

Caralynn Nowinski Collens

Chief Executive Officer of UI LABS

Prior to UI LABS, Dr. Nowinski Collens was Associate Vice President for Innovation & Economic Development at the University of Illinois. She spent her early career in venture capital and corporate finance, primarily focused on technology-based university spin-outs. As a graduate student, she co-founded SanoGene Therapeutics, an early-stage biotechnology company, where, as CEO, she led the company’s spin-out from the University of Illinois and raised a strategic equity investment. She serves on the board of Imerman Angels and is a member of ChicagoNEXT and the Illinois Innovation & Competitiveness Council.